Navigation Links
Many Phase 3 Cancer Drug Trials Yield Effective Medicines
Date:3/24/2008

nvestment in the cooperative oncology group system," which funds the trials, the study authors wrote. "The public can expect that about 25 percent to 50 percent of new cancer treatments that reach the stage of assessment in clinical trials will prove to be successful. This pattern of successes has become more consistent over time. However, our results also indicate that the absolute number of discoveries might be improved if the proportion of inconclusive trials is reduced."

Cancer is the second leading cause of death in the United States. Over the years, there have been continuous improvements made in survival and other outcomes, in large part due to the introduction of new treatments tested in clinical trials, according to background information in the study.

More information

The U.S. National Cancer Institute has more about cancer clinical trials.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, March 24, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Cancer treatments in phase 3 trials successful up to half of the time
2. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
3. MGH initiates phase I diabetes trial
4. Enrollment completed in 2 pivotal phase III studies of the investigational cancer drug vandetanib
5. Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
6. Akela Pharma initiates its first abuse deterrent opioid Phase I clinical trial
7. Affinium Pharmaceuticals, Ltd. Announces Initiation of a Phase I Clinical Trial for AFN-1252, its Novel Anti-staphylococcal Antibiotic
8. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
9. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
10. Hyperion Therapeutics Announces Enrollment of First Patient in Phase 2 Clinical Trial in Patients With Hepatic Encephalopathy
11. Positive results from phase 1 clinical trials of cuprindro
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Phase 3 Cancer Drug Trials Yield Effective Medicines
(Date:3/2/2015)... Minneapolis, Minnesota (PRWEB) March 02, 2015 ... a new strategic relationship with First Protective Insurance ... new initiative will allow First Protective affiliated advisors ... and implementation support that Secura Consultants delivers. ... is a national leader in the design and ...
(Date:3/1/2015)... Minneapolis, MN (PRWEB) March 02, 2015 ... leader in the ancillary benefits market, announced the ... product offering. PrimeStar Individual Vision Insurance launched today, ... Choice Vision plan will utilize the VSP® Vision ... providers in the private practice space. The PrimeStar ...
(Date:3/1/2015)... 01, 2015 Women’s Excellence is pleased ... terms on their website. There are over 75 terms ... time. , “This gives our patients a better understanding ... terminology that they may not understand. With this resource, our ... mobile optimized) and find terms and phrases that they may not ...
(Date:3/1/2015)... Los Angeles, CA (PRWEB) March 01, 2015 ... will now be possible when using the Quotes Pros ... now available including United auto insurance rates that are ... , Access to the updated agencies and prices available ... a consumer's zip code online. Every system user will ...
(Date:3/1/2015)... Raleigh, NC (PRWEB) March 01, 2015 ... the reason that so many sheet metal workers contract ... of this new report on its website. Click ... the Center for Construction Research and Training monitored 17,345 ... that a disproportionate number of them died of ...
Breaking Medicine News(10 mins):Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2Health News:Security Life Insurance Company Launches Individual Vision Insurance Product 2Health News:United Auto Insurance Rates Now Quoted at Consumer Insurance Portal Online 2Health News:New Study Finds Indirect Asbestos Exposure Can Raise Mesothelioma Risk for Sheet Metal Workers, According to Surviving Mesothelioma 2
... TUCSON, Ariz., July 7 The Providence Service Corporation (Nasdaq: ... in California as part of the state,s attempt to close ... we have stated previously, given that our programs in California ... Act (Proposition 63 of 2004), we do not expect to ...
... been linked to fatal overdoses , TUESDAY, July ... of fatal overdoses led U.S. health officials Tuesday ... of using pain medications containing propoxyphene, including Darvon ... of propoxyphene-containing products by adding boxed warnings that ...
... way to eat healthier without sacrificing taste just got easier. ... lovers are invited to discover the great taste of Barilla ... tries and is not completely satisfied with Barilla Whole Grain ... pasta. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090707/NY41858-a ...
... Crawford Canada,s Bill Johnstone has been named senior vice ... ; CRDB) Global Technical Services (GTS) for the Americas, ... and grow this market-leading service, the Company announced today. ... Crawford worldwide in the high-end, complex loss adjusting market. ...
... KNOXVILLE, Tenn., July 7 TeamHealth Medical Call ... its third Health Care Call Center certificate of ... accrediting organization that establishes quality standards for the ... provides comprehensive medical call center services including nurse ...
... King Pharmaceuticals, Inc. (NYSE: KG ) today announced ... Drug Application (NDA). The Company is not required by ... trials in order to provide additional safety or efficacy data ... of the resubmission plan, and in order to strengthen the ...
Cached Medicine News:Health News:Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 2Health News:FDA Mandates Tougher Warnings for Pain Pills 2Health News:Barilla(R) and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 2Health News:Barilla(R) and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 3Health News:Bill Johnstone Named Senior Vice President of Crawford's Global Technical Services for the Americas 2Health News:TeamHealth Medical Call Center Awarded Third Consecutive URAC Health Call Center Accreditation 2Health News:King Provides Additional Information on the REMOXY(R) NDA Resubmission Plan 2
(Date:3/2/2015)... 2015 Attorney Advertising -- Bronstein, Gewirtz ... behalf of purchasers of the securities of Vitae ... VTAE -News).  Such investors are advised to contact ... coordinator Eitan Kimelman at info@bgandg.com ... whether Vitae Pharmaceuticals and certain of its officers ...
(Date:3/2/2015)... 2015  CANTEL MEDICAL CORP. (NYSE: CMN ... CEO, will be presenting at the Sidoti & Company ... presentation is scheduled for 2:00 PM ET on Monday, ... New York . In addition, Mr. Krakauer, ... be available for separate one-on-one meetings during the day. ...
(Date:3/2/2015)... 2, 2015  CytomX, a biotechnology company developing ... announced the creation of scientific and clinical advisory ... the fields of cancer immunotherapy and antibody drug ... will provide guidance to CytomX on the development ... and Probody drug conjugates. The company identified advisors ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3
... developed in surgeon's desire to have the ... instrument with the strength to maneuver into ... bending or breaking. Arthrotek Hand Instruments are ... the surgeon's hand. This new generation of ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... Instruments were developed in surgeon's desire to ... having an instrument with the strength to ... of the bending or breaking. Arthrotek Hand ... conform to the surgeon's hand. This new ...
... were developed in surgeon's desire to have ... an instrument with the strength to maneuver ... the bending or breaking. Arthrotek Hand Instruments ... to the surgeon's hand. This new generation ...
Medicine Products: